ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2025
May Measurement Month 2022: an analysis of blood pressure screening results from Argentina.
Article in European heart journal supplements : journal of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High blood pressure (BP) continues to be the leading cause of disability and death in the world over the years. With an unacceptably low rate of diagnosis and control, it challenges health systems in most countries. Thus, the Argentine Society of Arterial Hypertension (SAHA), in accordance with the May Measurement Month (MMM) initiative of the International Society of Hypertension, implemented for the sixth consecutive year a high BP detection campaign. A voluntary cross-sectional survey was conducted in public spaces and health centres during the month of May 2022. Hypertension was defined as systolic BP of ≥140 mmHg and/or diastolic BP of ≥90 mmHg based on the second of two BP measurements, or in those receiving treatment for high BP. In total, 50 746 participants were examined, with a mean age of 54.8 (standard deviation 17.1) and 61.1% of whom were women. Of all participants, 30 361 (59.8%) had hypertension, of which 22 933 (75.5%) were aware, 21 997 (72.4%) were taking antihypertensive medication, and 10 116 (33.3%) were controlled to <140/90 mmHg. The mean BP was 131.7/80.4 (±20.8/±12.7) mmHg. After standardization by age and sex, 23 094 (45.5%) were found to have hypertension, of which 14 270 (61.8%) were aware of it. The poor level of hypertension control that is repeated over the years exposes insufficient efforts and ineffective strategies that should generate different approaches in both the medical field and in the community that reinforce strategies to increase awareness and control of hypertension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.